The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (4) , 1904-1920
Abstract
Background: Efforts to prevent recurrence in gastric cancer (GC) patients are limited by current incomplete understanding of the pathological mechanisms. The present study aimed to identify novel tumour metastasis-associated genes and investigate potential value of these genes in clinical diagnosis and therapy.Keywords
This publication has 49 references indexed in Scilit:
- Peroxisome proliferator‐activated receptor γ upregulates galectin‐9 and predicts prognosis in intestinal‐type gastric cancerInternational Journal of Cancer, 2014
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinomaNature, 2014
- The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cellsCarcinogenesis, 2013
- Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activationGut, 2013
- Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancerJournal of Biomedical Research, 2012
- 7th Edition of the AJCC Cancer Staging Manual: StomachAnnals of Surgical Oncology, 2010
- Role of the PPAR-γ System in Normal and Tumoral Pituitary Corticotropic Cells and Adrenal CellsNeuroendocrinology, 2010
- Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor‐Trichostatin A through Sp1 binding siteGlia, 2008
- SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosisBritish Journal of Cancer, 2008
- Effect of peroxisome proliferator activated receptor γ ligands on growth and gene expression profiles of gastric cancer cellsGut, 2004